---
title: "Cullinan Therapeutics, Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e103e223-6420-5795-bce5-450261fac1da
json: https://whiteintel.dev/api/public/dossier/e103e223-6420-5795-bce5-450261fac1da
identifier: sec:0001789972
jurisdiction: US
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# Cullinan Therapeutics, Inc.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001789972`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/e103e223-6420-5795-bce5-450261fac1da  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e103e223-6420-5795-bce5-450261fac1da  

## Ownership & control

### Owners / controllers

- **LYNX1 CAPITAL MANAGEMENT LP** (tenpercentowner) — https://whiteintel.dev/entity/82977e62-7e3d-59e3-98d8-edcc76e26045
- **NICHOLS WESTON** (tenpercentowner) — https://whiteintel.dev/entity/01c77766-8c7c-59e0-ab08-99e9711755b2
- **BVF GP HOLDINGS LLC** (tenpercentowner) — https://whiteintel.dev/entity/6bdd31f3-cff2-565b-b0b0-b3be8afac673
- **BVF INC/IL** (tenpercentowner) — https://whiteintel.dev/entity/c3788db9-7dee-589d-a6de-f535d1b919df
- **BVF PARTNERS L P/IL** (tenpercentowner) — https://whiteintel.dev/entity/2d1fe4be-fda1-5949-a4dc-2db0872357b2
- **LAMPERT MARK N** (tenpercentowner) — https://whiteintel.dev/entity/88b59549-d5c2-569d-a163-bc9f5aadeb62
- **GADICKE ANSBERT** (tenpercentowner) — https://whiteintel.dev/entity/3d6fb5d6-4514-5ca9-bf31-0f4073abbd96
- **JOVAN-EMBIRICOS MORANA** (tenpercentowner) — https://whiteintel.dev/entity/3abd3394-3e0a-59ae-a36a-e65da281cafc
- **F2 VISION SCS** (tenpercentowner) — https://whiteintel.dev/entity/262ecc5a-946d-56e2-8592-9d1b9a997e7f
- **F2 BIOSCIENCE I 2017 LTD** (tenpercentowner) — https://whiteintel.dev/entity/92f1c1f5-90d4-5e6b-b8dd-66e965f61219
- **ONCOLOGY IMPACT FUND (CAYMAN) MANAGEMENT L.P.** (tenpercentowner) — https://whiteintel.dev/entity/3a8e252b-5337-5cae-930c-c7ad7f0c7a8c
- **MPM ONCOLOGY IMPACT MANAGEMENT GP LLC** (tenpercentowner) — https://whiteintel.dev/entity/93475f72-06eb-56f1-93d8-5e97ac0d3306
- **UBS ONCOLOGY IMPACT FUND L.P.** (tenpercentowner) — https://whiteintel.dev/entity/4a6a304a-ea44-5174-bbeb-71a03fbf9ac2
- **BIOIMPACT CAPITAL LLC** (tenpercentowner) — https://whiteintel.dev/entity/612278c2-3057-5c19-8fb2-9d831fd505a6
- **F2 GC, LLC** (tenpercentowner) — https://whiteintel.dev/entity/f4ad7c88-0f13-531d-bab4-d4fd484fa50b
- **F2 - TPO INVESTMENTS LLC** (tenpercentowner) — https://whiteintel.dev/entity/896ba119-6192-5d0f-99be-92deb63482ed
- **GLOBEWAYS HOLDINGS LTD** (tenpercentowner) — https://whiteintel.dev/entity/740e888b-6f64-55f0-94de-ef680f6c1aa9
- **F2 MG LTD** (tenpercentowner) — https://whiteintel.dev/entity/e9714786-8f2a-5ae1-938d-90c3752a458e
- **F2 BIO TD, LLC** (tenpercentowner) — https://whiteintel.dev/entity/7c4f95ef-10d2-5301-b42e-e6bcbaa973e3
- **F2 MC, LLC** (tenpercentowner) — https://whiteintel.dev/entity/46cab0ae-f7af-52cf-9fa2-2c4d0fea668a

### UBO chain (walk to the ultimate owner)

A **64-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **Cullinan Therapeutics, Inc.** — https://whiteintel.dev/entity/e103e223-6420-5795-bce5-450261fac1da · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Cullinan Therapeutics, Inc.**. Human view: https://whiteintel.dev/entity/e103e223-6420-5795-bce5-450261fac1da · Structured JSON: https://whiteintel.dev/api/public/dossier/e103e223-6420-5795-bce5-450261fac1da._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._